Literature DB >> 24377980

Historical perspectives: The evolution of the thymic epithelial tumors staging system.

Pier Luigi Filosso1, Enrico Ruffini2, Paolo Olivo Lausi2, Marco Lucchi3, Alberto Oliaro2, Frank Detterbeck4.   

Abstract

Thymic epithelial tumors (thymomas, thymic carcinomas and neuroendocrine tumors - NETs) are rare primary mediastinal neoplasms, recently classified as orphan diseases. Their rarity might explain the fact that currently, no official staging system has been defined by the Union Internationale Contre le Cancer (UICC) and the American Joint Commission on Cancer (AJCC). However, the appropriate staging of these tumors has been matter of debate and several proposals have been published over the years, but very few have received a clinical validation. Recently an international database for thymic malignancies has been provided by the International Thymic Malignancy Interest Group (ITMIG); one of its aims is to accomplish a new and evidence based staging system, to allow progress in clinical management in thymic tumors. This paper will review the history of proposed staging systems, comparing resemblances and differences, being a sort of starting point for the development of a new widely accepted clinical staging system.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  History; Masaoka staging system; Staging system; TNM classification; Thymic carcinoma; Thymoma; Thymus

Mesh:

Year:  2013        PMID: 24377980     DOI: 10.1016/j.lungcan.2013.09.013

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  18 in total

1.  Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features.

Authors:  Hyun-Sung Lee; Hee-Jin Jang; Rohan Shah; David Yoon; Masatsugu Hamaji; Ori Wald; Ju-Seog Lee; David J Sugarbaker; Bryan M Burt
Journal:  Clin Cancer Res       Date:  2017-04-11       Impact factor: 12.531

2.  Clinical implication of the new TNM classification of thymic malignancies.

Authors:  Frank C Detterbeck
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

3.  Multimodality therapy for locally-advanced thymic epithelial tumors: where are we now?

Authors:  Pier Luigi Filosso; Francesco Guerrera; Alberto Sandri; Enrico Ruffini
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

Review 4.  Molecular strategies in the management of bronchopulmonary and thymic neuroendocrine neoplasms.

Authors:  Irvin M Modlin; Mark Kidd; Pier-Luigi Filosso; Matteo Roffinella; Anna Lewczuk; Jaroslaw Cwikla; Lisa Bodei; Agnieska Kolasinska-Cwikla; Kyung-Min Chung; Margot E Tesselaar; Ignat A Drozdov
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

5.  Risk stratification of thymic epithelial tumors by using a nomogram combined with radiomic features and TNM staging.

Authors:  Qijun Shen; Yanna Shan; Wen Xu; Guangzhu Hu; Wenhui Chen; Zhan Feng; Peipei Pang; Zhongxiang Ding; Wenli Cai
Journal:  Eur Radiol       Date:  2020-08-05       Impact factor: 5.315

Review 6.  Management of thymic tumors: a European perspective.

Authors:  Enrico Ruffini; Federico Venuta
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

7.  Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulation.

Authors:  Teresa Bellissimo; Federica Ganci; Enzo Gallo; Andrea Sacconi; Claudia Tito; Luciana De Angelis; Claudio Pulito; Silvia Masciarelli; Daniele Diso; Marco Anile; Vincenzo Petrozza; Felice Giangaspero; Edoardo Pescarmona; Francesco Facciolo; Federico Venuta; Mirella Marino; Giovanni Blandino; Francesco Fazi
Journal:  Mol Cancer       Date:  2017-05-10       Impact factor: 27.401

8.  Thymic carcinoma patients with myasthenia gravis exhibit better prognoses.

Authors:  Wenya Li; Zhifeng Miao; Xudong Liu; Qigang Zhang; Lei Sun; Peiwen Li; Wenke Liu; Lin Zhang
Journal:  Int J Clin Oncol       Date:  2015-07-03       Impact factor: 3.402

9.  Computed Tomography Features associated With the Eighth Edition TNM Stage Classification for Thymic Epithelial Tumors.

Authors:  Sukhmani K Padda; Donato Terrone; Lu Tian; Amanda Khuong; Joel W Neal; Jonathan W Riess; Mark F Berry; Chuong D Hoang; Bryan M Burt; Ann N Leung; Erich J Schwartz; Joseph B Shrager; Heather A Wakelee
Journal:  J Thorac Imaging       Date:  2018-05       Impact factor: 3.000

10.  Comparison of outcomes between neuroendocrine thymic tumours and other subtypes of thymic carcinomas: a joint analysis of the European Society of Thoracic Surgeons and the International Thymic Malignancy Interest Group.

Authors:  Pier Luigi Filosso; Xiaopan Yao; Enrico Ruffini; Usman Ahmad; Alberto Antonicelli; James Huang; Francesco Guerrera; Federico Venuta; Dirk van Raemdonck; William Travis; Marco Lucchi; Andreas Rimner; Pascal Thomas; Walter Weder; Gaetano Rocco; Frank Detterbeck; Robert Korst
Journal:  Eur J Cardiothorac Surg       Date:  2016-03-31       Impact factor: 4.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.